3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
2
Carcinoma, Non-Small-Cell Lung
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms
1
Multiple Myeloma
1
Medulloblastoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Cyclophosphamide
7
Mycophenolic Acid
5
Whole-Body Irradiation
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Tacrolimus
3
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
Cyclosporine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Vemurafenib
×
30 days
×
Clear all
No trials found.